Chemitex: reported China–Brazil cooperation
Chemitex describes cooperation with Zhejiang Jiuzhou in its own corporate news. Read the statement for its stated scope and date.
Read details →Evidence Library
Evidence Library
Read the document, its scope and its limitations. Public context does not imply affiliation.
Companies in public sources →Companies, institutions and data are cited as public industry context. These references do not imply partnership, endorsement, certification or a commercial relationship with our company.
7 records found
China in pharmaceutical supply chains
The selected public sources describe industry supply chains. Their scope is separate from the facilities or services available for an individual quotation.
Read details →China–Brazil pharmaceutical trade
The linked WITS data concerns pharmaceutical trade under HS chapter 30. It is not a peptide-only series or a record of BLOPEP sales.
Read details →China–US pharmaceutical trade
Read the linked trade record with its product classification, reporting period, currency and unit. Aggregate trade does not identify a specific peptide transaction.
Read details →Eli Lilly: supply-chain disclosure
The linked 2025 disclosure discusses China-based suppliers for parts of the supply chain, including chemical synthesis inputs.
Read details →Reading peptide-market reports
Market reports use different definitions, time periods and estimation methods. Compare those assumptions before comparing their figures.
Read details →WuXi AppTec: peptide manufacturing capacity
The company disclosure describes SPPS capacity and expansion plans. Distinguish capacity reported at a stated date from a future target.
Read details →